SGYP.OB: Summary for SYNERGY PHARMACEUTCL - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 3:51am EST - Canadian Markets open in 5 hours and 39 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Synergy Pharmaceuticals, Inc. (SGYP.OB)

On Feb 5: 6.40 USD 0.00 (0.00%)

MORE ON SGYP.OB

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

SYNERGY PHARMACEUTCL (OTC BB:SGYP.OB) Delayed quote data

Last Trade:	6.40 USD
Trade Time:	Feb 5
Change:	0.00 (0.00%)
Prev Close:	6.40
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	2.62 - 10.00
Volume:	0
Avg Vol (3m):	865.079
Market Cap:	563.88M
P/E (ttm):	N/A
EPS (ttm):	-0.10
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y

Add SGYP.OB to Portfolio

Download Data

HEADLINES

•	SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
	EDGAR Online (Fri, Feb 5)

•	Synergy Pharmaceuticals to Present at the 8th Annual BioPartnering North America (BPN) Conference in Vancouver, BC, Canada
	Business Wire (Fri, Jan 22)

•	SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
	EDGAR Online (Fri, Jan 8)

•	SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fi
	EDGAR Online (Mon, Dec 7)

•	SYNERGY PHARMACEUTICALS, INC. Financials
	EDGAR Online Financials (Fri, Nov 20)

•	SYNERGY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Mon, Nov 16)

•	Synergy Pharmaceuticals Raises $8.6 Million in Common Stock Financing
	Business Wire (Thu, Nov 12)

•	SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure
	EDGAR Online (Mon, Nov 9)

•	SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Eq
	EDGAR Online (Thu, Nov 5)

•	SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure
	EDGAR Online (Fri, Oct 9)

More Headlines for SGYP.OB...

BUSINESS SUMMARY

Synergy Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases.

Full Company Profile

Add to Portfolio

Email to a Friend

•